Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Bioimpacts : BI|October 9, 2025
microRNAs shuttled by mesenchymal stromal cell-derived exosomes in coronary artery disease: A systematic review of preclinical studiesSoroush Mostafavi, Amin Arasteh, Seyedeh Mina Mostafavi Montazeri, et al.Plos One|February 12, 2026
Remdesivir may exacerbate ischemic acute kidney injury through molecular alterations in PGC-1α and apoptosis pathways: An in vivo studyYasin Bagheri, Zahra Malekinejad, Seyyedeh Mina Hejazian, et al.Cell Communication and Signaling : CCS|December 19, 2024
Targeting cellular senescence in kidney diseases and aging: A focus on mesenchymal stem cells and their paracrine factorsSeyyedeh Mina Hejazian, Seyyed Sina Hejazian, Seyyedeh Mina Mostafavi, et al.Fetal and Pediatric Pathology|August 7, 2023
Decoding the Possible Molecular Mechanisms in Pediatric Wilms Tumor and Rhabdoid Tumor of the Kidney through Machine Learning ApproachesSeyed Mahdi Hosseiniyan Khatibi, Yalda Rahbar Saadat, Seyyedeh Mina Hejazian, et al.Biofactors (Oxford, England)|October 8, 2020
Glucocorticoid receptors and their upstream epigenetic regulators in adults with steroid-resistant nephrotic syndromeYalda Rahbar Saadat, Seyyedeh Mina Hejazian, Ziba Nariman-Saleh-Fam, et al.Peerj|December 28, 2020
Dysregulated levels of glycogen synthase kinase-3β (GSK-3β) and miR-135 in peripheral blood samples of cases with nephrotic syndromeMohammadreza Ardalan, Seyyedeh Mina Hejazian, Hassan Fazlazar Sharabiyani, et al.Expert Review of Clinical Pharmacology|December 19, 2019
Steroid-resistant nephrotic syndrome: pharmacogenetics and epigenetic points and viewsSeyede Mina Hejazian, Sepideh Zununi Vahed, Hakimeh Moghaddas Sani, et al.Methods (San Diego, Calif.)|March 9, 2025
Milking mesenchymal stem cells: Updated protocols for cell lysate, secretome, and exosome extraction, and comparative analysis of their therapeutic potentialSepideh Zununi Vahed, Seyyedeh Mina Hejazian, William Ndjidda Bakari, et al.Life Sciences|October 16, 2020
Nrf-2 as a therapeutic target in acute kidney injurySeyyedeh Mina Hejazian, Seyed Mahdi Hosseiniyan Khatibi, Abolfazl Barzegari, et al.Inflammopharmacology|June 20, 2022
Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trialMohammadreza Moslemi, Seyyedeh Mina Hejazian, Molod Shaddelan, et al.Pageof 4